ACE inhibitors in acute myocardial infarction.
Approximately 50% of patients recovering from acute myocardial infarction have significant left ventricular systolic dysfunction and could benefit considerably from the long-term administration of angiotensin-converting enzyme inhibitors. This article summarizes the evidence for the use of these drugs and addresses the practical issues involved in their administration.
Murdoch
D R
DR
University of Glasgow.
McMurray
J J
JJ
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D018579:Patient Selection; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D005343:Fibrinolytic Agents; D001241:Aspirin